Evidence map›Paper›PMID 36567685›Full record

Observational studyF1000Research2022

Effectiveness, survival and safety of guselkumab attending to basal characteristics in moderate-to-severe psoriatic patients: a cohort study.

Ricardo Ruiz-Villaverde, Lourdes Rodriguez-Fernandez-Freire, Jose C Armario-Hita, Amalia Pérez-Gil, Fiorella Vasquez Chinchay, Manuel Galán-Gutiérrez

Open access · goldAbstract readObservational StudyCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Observational study in F1000Research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 1 country.

Ricardo Ruiz-VillaverdeDermatology Department, Hospital Universitario San Cecilio, Granada, 18016, Spain.ORCID 0000-0002-0381-6174
Lourdes Rodriguez-Fernandez-FreireDermatology Department, Hospital Universitario Virgen del Rocio, Sevilla, 41013, Spain.
Jose C Armario-HitaDermatology Department, Hospital Universitario Puerto Real, Cádiz, 11510, Spain.
Amalia Pérez-GilDermatology Department, Hospital Universitario Virgen de Valme, Sevilla, 41014, Spain.
Fiorella Vasquez ChinchayDermatology Department, Hospital Quirón Salud Sagrado Corazón, Sevilla, 41013, Spain.
Manuel Galán-GutiérrezDermatology Department, Hospital Universitario Reina Sofía, Córdoba, 14004, Spain.
Hospital Quirónsalud Sagrado Corazón · ESHospital Universitario de Valme · ESHospital Universitario Puerto Real · ESHospital Universitario Reina Sofía · ESHospital Universitario Virgen del Rocío · ESInstituto de Investigación Biosanitaria de Granada · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

PsoriasisQuality of LifeAntibodies, Monoclonal, HumanizedCohort StudiesFemaleHumansSeverity of Illness IndexAntibodies, Monoclonal, HumanizedguselkumabDemographic characteristicsEffectivenessGuselkumabPsoriasisSafetySurvival

Identifiers

PMID36567685
PMCPMC9755754
OpenAlexW4306409731

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.